Skip to main content
Clinical Trials/NCT06482281
NCT06482281
Active, not recruiting
Not Applicable

COVID-19 and Childhood Cancer - Diagnostic Delay, Survival, and COVID-19 Susceptibility

Karolinska Institutet1 site in 1 country100,000 target enrollmentJanuary 1, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
COVID-19
Sponsor
Karolinska Institutet
Enrollment
100000
Locations
1
Primary Endpoint
Childhood cancer survival
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

The investigators will first examine the impact of the COVID-19 pandemic on childhood cancer patients in Sweden and Denmark, both regarding susceptibility to severe COVID-19 among long-term childhood cancer survivors, and, for those diagnosed with childhood cancer during the pandemic, whether the path through primary care to cancer diagnosis as well as short-term survival has changed. Second, the investigators will study childhood cancer incidence before, during and after the pandemic with the particular aim to test the hypothesis regarding an infectious disease etiology for acute lymphoblastic leukemia.

Registry
clinicaltrials.gov
Start Date
January 1, 2023
End Date
December 31, 2025
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Giorgio Tettamanti

Senior research specialist, Docent

Karolinska Institutet

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • No exclusion criteria

Outcomes

Primary Outcomes

Childhood cancer survival

Time Frame: After three and twelve months after the cancer diagnosis and three years after cancer diagnosis

Overall survival after a childhood cancer diagnosis

Severe COVID-19

Time Frame: Up to 3 years

Defined as: * death with COVID-19 listed as a cause of death * hospitalization, or admission to intensive care unit, because of COVID-19 (main diagnosis) or respiratory problems (main diagnosis) AND COVID-19 as secondary diagnosis

Number of contacts before childhood cancer diagnosis

Time Frame: One year before cancer diagnosis

Number of healthcare contacts (including primary care) the year before the cancer diagnosis

Childhood cancer incidence

Time Frame: From 2015

Age standardized incidence rates for childhood cancer and cancer subtypes (particularly acute lymphoblastic leukemia) in Sweden and Denmark during and after the pandemic and compare it to the 5 years preceding the pandemic

Study Sites (1)

Loading locations...

Similar Trials